best syringe for retatrutide and the Grey Market: Buyer Beware – Sarah Hormachea Syringe dose for 0.5mg :

More important than my observation is the following: In comments by Thompson and Sturmer published in the journal Diabetes Care in 2023, about a study of GLP-1s and the risk of thyroid cancer conducted by Bezin et al which was published in the same journal issue, Thompson and Sturmer conclude that Thyroid cancer is a rare outcome, however, and the potential increase in absolute risk is very small

Data on adverse events were sourced from the product information of the EMA

Consult a licensed physician for personal medical decisions

The GLP-1 group also had a higher kidney cancer risk at 3 years (HR = 2.09

Prescription GLP-1 medications arent available or affordable for everyone, and the promise of a lower-cost alternative like a patch can be very appealing